Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways

Journal of Neurochemistry

Volumn 109, Issue 5, 2009, Pages 1338-1347

  Gao, Quan Gui ^a,b   Chen, Wen Fang ^a,b   Xie, Jun Xia ^a   Wong, Man Sau ^b  

^a QINGDAO UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

6 hydroxydopamine; Estrogen receptor; Ginsenoside Rg1; Insulin like growth factor I receptor; SK N SH cells

Indexed keywords

ESTROGEN RECEPTOR; FULVESTRANT; GINSENOSIDE RG 1; OXIDOPAMINE; SOMATOMEDIN BINDING PROTEIN 1;

ARTICLE; CELL CYCLE S PHASE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADRENERGIC AGENTS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GINSENOSIDES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 65549127731     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06051.x     Document Type: Article

References (43)

1. Ballif B. A. Blenis J. (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 12, 397 408. (Pubitemid 32762689)
2. Bondy C. A. Cheng C. M. (2004) Signaling by insulin-like growth factor I in brain. Eur. J. Pharmacol. 490, 25 31. (Pubitemid 38482159)
3. Callier S., Morissette M., Grandbois M., Pélaprat D. Di Paolo T. (2001) Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse 41, 131 138. (Pubitemid 32538605)
4. Cardona-Gomez G. P., DonCarlos L. Garcia-Segura L. M. (2000) Insulin-like growth factor I receptors and estrogen receptors colocalizein female rat brain. Neuroscience 99, 751 760.
5. Chan R. Y., Chen W. F., Dong A., Guo D. A. Wong M. S. (2002) Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J. Clin. Endocrinol. Metab. 87, 3691 3695.
6. Chen W. F. Wong M. S. (2004) Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J. Clin. Endocrinol. Metab. 89, 2351 2359. (Pubitemid 38619875)
7. Chen X. C., Chen Y., Zhu Y. G., Fang F. Chen L. M. (2002) Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons. Acta. Pharmacol. Sin. 23, 829 834.
8. +-induced apoptosis in SHSY5Y cells. J. Neural. Transm. 110, 835 845. (Pubitemid 36981401)
9. Chen W. F., Lau W. S., Cheung P. Y., Guo D. A. Wong M. S. (2006) Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1. Br. J. Pharmacol. 147, 542 551. (Pubitemid 43355052)
10. Cohen J. J., Duke R. C., Fadok V. A. Sellins K. S. (1992) Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10, 267 293.
11. Cory S. Adams L. M. (2002) The Bcl-2 family, regulators of cellular life-or-death switch. Nat. Rev. Cancer 2, 647 656. (Pubitemid 37328916)
12. Datla K. P., Murray H. E., Pillai A. V., Gillies G. E. Dexter D. T. (2003) Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle. Neuroreport 14, 47 50. (Pubitemid 36160740)
13. Emdadual H. M., Masato A., Youichirou H., Ikuko M., Ken-ichi T. Norio O. (2003) Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim. Biophys. Acta 1619, 39 52. (Pubitemid 35462118)
14. Fornstedt B., Rosengren E. Carlsson A. (1986) Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmcology 25, 451 454. (Pubitemid 16109584)
15. Gorman A. M., Orrenius S. Ceccateli S. (1998) Apoptosis in neuronal cells: role of caspases. Neuroreport 9, 49 55. (Pubitemid 28338197)
16. Guan J., Krishnamurthi R., Waldvogel H. J., Faull R. L., Clark R. Gluckman P. (2000) N-terminal tripeptide of IGF-I (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res. 859, 286 292. (Pubitemid 30136100)
17. Huang Y. S., Yang Z. C., Yan B. G., Hu X. C., Li A. N. Crowther R. S. (1999) Improvement of early postburn cardiac function by use of Panax notoginseng and immediate total eschar excision in one operation. Burns 25, 35 41. (Pubitemid 29092462)
18. Ishunina T. A., Fischer D. F. Swaab D. F. (2007) Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol. Aging 28, 1670 1681. (Pubitemid 47384954)
19. Kar S., Seto D., Dore S., Hanisch U. Quirioin R. (1997) Insulin-like growth factor-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation. Proc. Natl Acad. Sci. USA 94, 14054 14059. (Pubitemid 28009708)
20. Kluck R. M., Martin S. J., Zhou J. S., Green D. R. Newmeyer D. D. (1996) Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16, 4639 4649.
21. Krishnamurthi R., Stott S., Maingay M., Faull R. L., McCarthy D., Gluckman P. Guan J. (2004) N-terminal tripeptide of IGF-I improves functional deficits after 6-OHDA lesion in rats. Neuroreport 15, 1601 1604. (Pubitemid 38971179)
22. Lau W. S., Chan R. Y., Guo D. A. Wong M. S. (2008) Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J. Steroid Biochem. Mol. Biol. 108, 64 71.
23. Laviola L., Natalicchio A. Giorgino F. (2007) The IGF-I signaling pathway. Curr. Pharm. Des. 13, 663 669. (Pubitemid 46510743)
24. Lee H., Jiang F., Wang Q., Nicosia S. V., Yang J., Su B. Bai W. (2000) MEKK1 activation of human estrogen receptor and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. Mol. Endocrinol. 14, 1882 1896.
25. Leung K. W., Yung K. K., Mak N. K., Chan Y. S., Fan T. P. Wong R. N. (2007) Neuroprotective effects of ginsenoside Rg1 in primary nigral neurons against rotenone toxicity. Neuropharmacology 52, 827 835. (Pubitemid 46227475)
26. Liu C. X. Xiao P. G. (1992) Recent advances on ginseng research in China. J. Ethnopharmacol. 36, 27 38.
27. Morissette M., Al Sweidi S., Callier S. Di Paolo T. (2008) Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol. Cell. Endocrinol. 290, 60 69.
28. Murray H. E., Pillai A. V., McArthur S. R., Razvi N., Datla K. P., Dexter D. T. Gillies G. E. (2003) Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Neuroscience 116, 213 222. (Pubitemid 36110447)
29. Nicholls D. G. Budd S. L. (2000) Mitochondrial and neuronal survival. Physiol. Rev. 80, 315 360.
30. Perillo B., Sasso A., Abbondanza C. Palumbo G. (2000) 17β-Estradiol inhibits apoptosis in MCF-7 Cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell. Biol. 20, 2890 2901. (Pubitemid 30183508)
31. Quesada A. Micevyvh P. E. (2004) Estrogen interacts with the IGF-I system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J. Neurosci. Res. 75, 107 116. (Pubitemid 38049411)
32. Quesada A., Romeo H. E. Micevych P. (2007) Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra. J. Comp. Neurol. 503, 198 208. (Pubitemid 47024427)
33. Radad K., Gille G., Moldzio R., Satio H. Rausch W. D. (2004a) Ginsenoside Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res. 1021, 41 53.
34. +-affected mesencephalic dopaminergic cells. J. Neural. Transm. 111, 37 45. (Pubitemid 38177816)
35. Ramirez A. D., Liu X. Menniti F. S. (2003) Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice. Neuroendocrinology 77, 223 231. (Pubitemid 36667656)
36. Saunders-Pullman R., Gordon-Elliott J. Parides M. (1999) The effect of estrogen replacement on early Parkinson's disease. Neurology 52, 1417 1421. (Pubitemid 29190534)
37. Seaton T. A., Cooper J. M. Schapria A. H. (1997) Free radical scavengers protect dopaminergic cell line from apoptosis induced by mitochondrial complex I toxins. Brain Res. 777, 110 118. (Pubitemid 28015738)
38. Shimizu E., Hashimoto K., Komatsu N. Iyo M. (2002) Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells. Neuropharmacology 43, 434 443. (Pubitemid 35257935)
39. Shoji S. (2001) Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci. 16, S28 37.
40. Shulman L. M. Bhat V. (2006) Gender disparities in Parkinson's disease. Expert. Rev. Neurother. 6, 407 416.
41. Tohda C., Matsumoto N., Zou K., Meselhy M. R. Komatsu K. (2002) Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cell. Jpn. J. Pharmacol. 90, 254 262. (Pubitemid 35422943)
42. Wooten G. F., Currie L. J., Bovbjerg V. E., Lee J. K. Patrie J. (2004) Are men at greater risk for Parkinson's disease than women? J. Neurol. Neurosurg. Psychiatry 75, 637 639. (Pubitemid 38406668)
43. Zhao D. L., Zou L. B., Lin S., Shi J. G. Zhu H. B. (2007) Anti-apoptosis effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 53, 724 732. (Pubitemid 47542334)